Inovio
-
Plymouth Meeting-based Inovio Delays FDA Approval Plans for Experimental DNA Drug
Plymouth Meeting-based Inovio is delaying plans to seek Food and Drug Administration approval for its experimental DNA medicine as a…
-
Plymouth Meeting’s Inovio Shares Spike After Positive FDA Reception on Groundbreaking Treatment
Plymouth Meeting biotech company Inovio’s innovations are paying off. Amid positive feedback from the FDA on an experimental respiratory disease…
-
Inovio Pulls Development of Two Vaccines; Stock-Price Health Weakens in Response
Plymouth Meeting pharmaceutical company Inovio has discontinued development of two vaccines, based on evidence of their ineffectiveness. As a result,…
-
Plymouth Meeting Biopharma Co. Turns Focus Inward to Heal Itself by Cutting Costs
Plymouth Meeting biopharma firm Inovio, working to cure its own ills, is undergoing a reorg. The multiple measures it is…
-
Plymouth Meeting-based Inovio is Latest Stock to Benefit from Attention of Reddit’s Individual Investors
Plymouth Meeting-based Inovio saw its stock jump 33 percent on Monday after the biotech company came to the attention of…
-
Thermo Fisher Scientific to Manufacture Inovio’s DNA-Based COVID-19 Vaccine
Plymouth Meeting-based Inovio has signed a manufacturing deal with Thermo Fisher for its experimental DNA-based Covid-19 vaccine candidate, writes John…
-
Pandemic Could Mark Turning Point for Plymouth-based Inovio’s DNA Vaccine Technology
The coronavirus pandemic could mark a turning point for DNA vaccine technology that has been three decades in the making…
-
Plymouth Meeting-Based Inovio Within Reach of COVID-19 Vaccine Breakthrough
With the DNA technology Inovio is basing its COVID-19 vaccine on still experimental after nearly four decades of research and…
-
Pandemic Could Mark Turning Point for Inovio’s DNA Vaccine Technology
The coronavirus pandemic could mark a turning point for DNA vaccine technology that has been three decades in the making…
-
Inovio CEO Tells Wired How DNA-Based COVID-19 Vaccine Differs from Traditional Vaccines
While most traditional vaccines are created using a weakened or dead version of a virus that is injected into the…
-
Plymouth Meeting’s Inovio Alleges Supplier Is Withholding Critical Information on COVID-19 Vaccine
Plymouth Meeting-based Inovio Pharmaceuticals has filed a complaint with Pennsylvania state court alleging that a supplier is holding its experimental…
-
Plymouth Meeting-Based Inovio Pharmaceuticals’ Partner Wins $11.9M DoD COVID-19 Vaccine Contract
Ology Bioservices has won an $11.9 million Department of Defense contract to work on a potential COVID-19 vaccine with Plymouth…
-
Plymouth Meeting-Based Inovio Pharmaceuticals Receives Grant to Develop Vaccine for Newly Identified Coronavirus in China
Plymouth Meeting-based Inovio Pharmaceuticals has been awarded a grant of up to $9 million to rapidly develop a vaccine for…
-
Plymouth Meeting’s Inovio Sees Promising Results from Early Patient Tests of HIV Vaccine
Shares of Inovio Pharmaceuticals soared last week after the Plymouth Meeting biotech announced promising results from preliminary patient testing of…
-
Plymouth Meeting’s Inovio Pharmaceuticals to test DNA based Vaccine for HIV
Plymouth Meeting’s Inovio Pharmaceuticals is collaborating with the University of California to test its new DNA based vaccine for the…
-
Montgomery County Careers – Inovio Pharmaceuticals
Plymouth Meeting’s Inovio Pharmaceuticals is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
